A 75-year-old woman with rheumatoid arthritis and multiple myeloma was admitted to the hospital with abdominal pain. She had ...

In four patients with severe autoimmune disease, teclistimab, a bispecific antibody to B-cell maturation antigen and CD3, ...

A woman with aggressive refractory systemic lupus erythematosus was treated with a short course of the bispecific antibody ...

For permission requests, please contact NEJM Reprints at [email protected] Clinicians routinely provide harm-reduction measures and anticipatory guidance for a range of complex health issues (e.g ...

Adjuvant therapy with durvalumab, with or without tremelimumab, may have efficacy in patients with limited-stage small-cell lung cancer who do not have disease progression after standard ...

For permission requests, please contact NEJM Reprints at [email protected] Panel A shows dereplicated reads from wastewater virome sequencing assigned to H5N1 from all samples with a validated ...

Tickborne virus infections are a global health problem that are associated with considerable morbidity and mortality. 1,2 Over the past decade, several emerging tickborne viruses associated with ...

The overall risk of malignancy in pancreatic cysts may be as low as 0.5 to 1.5%, and the annual risk of progression is 0.5%. 7,15 Conversely, studies estimate that 15% of all pancreatic ...

No medications are currently approved for the treatment of nonmonogenic, nonsyndromic obesity in children younger than 12 years of age. Although the use of liraglutide has been shown to induce ...

A potential mediator of migraine pathogenesis is the signaling molecule pituitary adenylate cyclase–activating polypeptide (PACAP). 5 Experimental studies have shown that intravenous infusion of ...

In this audio interview, Editor-in-Chief Eric Rubin and NEJM Evidence Associate Editor Oladapo Yeku discuss research being presented at the 2024 European Society of Medical Oncology annual meeting.